Microdose Psychedelic Insights (“Microdose”) are set to host their virtual Pyschedelic Capital: July 2021 conference on July 29, 2021. The event is set to play host to a number of companies, drawn from across the psychedelics industry, including, but not limited to, the functional mushrooms and phytopharmaceutical sectors.
Microdose Psychedelic Insights, a cutting-edge media company focused around promoting content, financial analysis, and engaging events focused around the psychedelics industry, have gained renown for their unique vision towards shifting the global perception around psychedelic medicine through a series of innovative events.
Part of an investor conference series diving deep into psychedelic medicine investment, Microdose’s Psychedelic Capital conference seeks to introduce investors and attendees to a curated group of CEOs, capital advisors and investment luminaries from around the world. This year’s July conference will be inaugurated by an introductory talk, delivered by Patrick Moher, CEO of Microdose Psychedelic Insights; and Richard Skaife, Founding Partner at The Conscious Fund, an early-stage venture capital investor within the plant powered medicine sector.
The conference will subsequently play host to a number of corporate presentations from companies focused around medicinal mushroom-based products, the cultivation and processing of pharmaceutical and medicinal cannabis, psychedelic-based disease modifying therapies, among various others.
In addition, the event will also feature an exciting roundtable symposium focused around the latest ongoing developments and breakthroughs within the global psychedelics industry.
Additional information about the Psychedelic Capital: July 2021 conference, as well as details for registration, can be found on the Psychedelic Capital conference website at https://microdose.buzz/shop/events/psychedelic-capital/psychedelic-capital-jul-2021/
About Microdose Psychedelic Insights:
Microdose Psychedelic Insights is your guide to the psychedelic medicine industry. With a vision to shift the world’s perception of psychedelic medicine, we distribute and create the most compelling content, financial analysis, engaging events, and groundbreaking education to drive the psychedelics industry to the forefront of modern medicine.
About Psychedelic Capital:
This online event programming is dedicated to providing investment grade information for the nascent psychedelic sector and presents a curated group of CEOs, financial experts, thought leaders and investment luminaries from around the globe. Presentations are 30 minutes in length, with 10 minutes always allocated to a one-on-one Q&A session with the audience. Psychedelic Capital features the top companies, latest IPOs, newest opportunities and deepest insights into the emerging psychedelic space.
Contact: Microdose Psychedelic Insights kristina@microdose.buzz
Media Contact: InvestorBrandNetwork (IBN) Los Angeles, California www.InvestorBrandNetwork.com 310.299.1717 Office Editor@InvestorBrandNetwork.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment